{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:56:47Z","timestamp":1777730207682,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00120-025-02747-7","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T20:57:08Z","timestamp":1765918628000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PARP-(Poly-Adenosindiphosphat-Ribose-Polymerase)Inhibitor-Kombinationstherapie beim metastasierten kastrationsresistenten Prostatakarzinom","Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer"],"prefix":"10.1007","volume":"65","author":[{"given":"Carsten","family":"Ohlmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura-Maria","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2747_CR1","unstructured":"Fachinformation Lynparza (Jun 2025)"},{"issue":"5","key":"2747_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson\u00a0D et\u00a0al (2015) Cell 161(5):1215\u20131228. https:\/\/doi.org\/10.1016\/j.cell.2015.05.001","journal-title":"Cell"},{"issue":"10","key":"2747_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S1470-2045(23)00382-0","volume":"24","author":"F Saad","year":"2023","unstructured":"Saad\u00a0F et\u00a0al (2023) Lancet Oncol 24(10):1094\u20131108. https:\/\/doi.org\/10.1016\/S1470-2045(23)00382-0","journal-title":"Lancet Oncol"},{"issue":"6_suppl","key":"2747_CR4","doi-asserted-by":"publisher","first-page":"LBA1","DOI":"10.1200\/JCO.2023.41.6_suppl.LBA1","volume":"41","author":"N Agarwal","year":"2023","unstructured":"Agarwal\u00a0N et\u00a0al (2023) J\u00a0Clin Oncol 41(6_suppl):LBA1. https:\/\/doi.org\/10.1200\/JCO.2023.41.6_suppl.LBA1","journal-title":"J Clin Oncol"},{"key":"2747_CR5","unstructured":"Fachinformation Talzenna (Jun 2025)"},{"key":"2747_CR6","unstructured":"Fachinformation Akeega (Jul 2024)"},{"issue":"11","key":"2747_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1158\/2159-8290.CD-13-0172","volume":"3","author":"WR Polkinghorn","year":"2013","unstructured":"Polkinghorn\u00a0WR et\u00a0al (2013) Cancer Discov 3(11):1245\u20131253. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0172","journal-title":"Cancer Discov"},{"issue":"480","key":"2747_CR8","doi-asserted-by":"publisher","first-page":"eaam7479","DOI":"10.1126\/scisignal.aam7479","volume":"10","author":"L Li","year":"2017","unstructured":"Li\u00a0L et\u00a0al (2017) Sci Signal 10(480):eaam7479. https:\/\/doi.org\/10.1126\/scisignal.aam7479","journal-title":"Sci Signal"},{"issue":"2","key":"2747_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ Lord","year":"2016","unstructured":"Lord\u00a0CJ et\u00a0al (2016) Nat Rev Cancer 16(2):110\u2013120. https:\/\/doi.org\/10.1038\/nrc.2015.21","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2747_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1158\/2159-8290.CD-12-0120","volume":"2","author":"MJ Schiewer","year":"2012","unstructured":"Schiewer\u00a0MJ et\u00a0al (2012) Cancer Discov 2(12):1134\u20131149. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0120","journal-title":"Cancer Discov"},{"key":"2747_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41467-017-00393-y","volume":"8","author":"M Asim","year":"2017","unstructured":"Asim\u00a0M et\u00a0al (2017) Nat Commun 8:374. https:\/\/doi.org\/10.1038\/s41467-017-00393-y","journal-title":"Nat Commun"},{"issue":"11","key":"2747_CR12","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.3390\/cancers14112640","volume":"14","author":"R Abbotts","year":"2022","unstructured":"Abbotts\u00a0R et\u00a0al (2022) Cancers 14(11):2640. https:\/\/doi.org\/10.3390\/cancers14112640","journal-title":"Cancers"},{"issue":"7","key":"2747_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S1470-2045(18)30365-6","volume":"19","author":"N Clarke","year":"2018","unstructured":"Clarke\u00a0N et\u00a0al (2018) Lancet Oncol 19(7):975\u2013986. https:\/\/doi.org\/10.1016\/S1470-2045(18)30365-6","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"2747_CR14","doi-asserted-by":"publisher","first-page":"TPS5588","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS5588","volume":"38","author":"KN Chi","year":"2020","unstructured":"Chi\u00a0KN et\u00a0al (2020) J\u00a0Clin Oncol 38(15_suppl):TPS5588. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.TPS5588","journal-title":"J Clin Oncol"},{"key":"2747_CR15","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200043","author":"NW Clarke","year":"2022","unstructured":"Clarke\u00a0NW et\u00a0al (2022) NEJM Evid. https:\/\/doi.org\/10.1056\/EVIDoa2200043","journal-title":"NEJM Evid"},{"key":"2747_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.09.013","author":"NW Clarke","year":"2024","unstructured":"Clarke\u00a0NW et\u00a0al (2024) Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2024.09.013","journal-title":"Eur Urol Oncol"},{"issue":"5_suppl","key":"2747_CR17","doi-asserted-by":"publisher","first-page":"LBA18","DOI":"10.1200\/JCO.2025.43.5_suppl.LBA18","volume":"43","author":"N Agarwal","year":"2025","unstructured":"Agarwal\u00a0N et\u00a0al (2025) J\u00a0Clin Oncol 43(5_suppl):LBA18. https:\/\/doi.org\/10.1200\/JCO.2025.43.5_suppl.LBA18","journal-title":"J Clin Oncol"},{"issue":"1","key":"2747_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41591-023-02704-x","volume":"30","author":"K Fizazi","year":"2024","unstructured":"Fizazi\u00a0K et\u00a0al (2024) Nat Med 30(1):257\u2013264. https:\/\/doi.org\/10.1038\/s41591-023-02704-x","journal-title":"Nat Med"},{"key":"2747_CR19","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1200\/JCO.22.0164","volume":"41","author":"KN Chi","year":"2023","unstructured":"Chi\u00a0KN et\u00a0al (2023) J\u00a0Clin Oncol 41:3339\u20133351. https:\/\/doi.org\/10.1200\/JCO.22.0164","journal-title":"J Clin Oncol"},{"issue":"6_suppl","key":"2747_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1200\/JCO.2023.41.6_suppl.170","volume":"41","author":"E Efstathiou","year":"2023","unstructured":"Efstathiou\u00a0E et\u00a0al (2023) J\u00a0Clin Oncol 41(6_suppl):170. https:\/\/doi.org\/10.1200\/JCO.2023.41.6_suppl.170","journal-title":"J Clin Oncol"},{"issue":"6_suppl","key":"2747_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1200\/JCO.2023.41.6_suppl.172","volume":"41","author":"E Castro","year":"2023","unstructured":"Castro\u00a0E et\u00a0al (2023) J\u00a0Clin Oncol 41(6_suppl):172. https:\/\/doi.org\/10.1200\/JCO.2023.41.6_suppl.172","journal-title":"J Clin Oncol"},{"issue":"suppl_7","key":"2747_CR22","doi-asserted-by":"publisher","first-page":"S808","DOI":"10.1016\/j.annonc.2022.07.1945","volume":"33","author":"F Saad","year":"2022","unstructured":"Saad\u00a0F et\u00a0al (2022) Ann Oncol 33(suppl_7):S808\u2013S869. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.1945","journal-title":"Ann Oncol"},{"key":"2747_CR23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.6_suppl.LBA16","author":"N Clarke","year":"2023","unstructured":"Clarke\u00a0N et\u00a0al (2023) J\u00a0Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2023.41.6_suppl.LBA16","journal-title":"J Clin Oncol"},{"issue":"suppl\u00a017","key":"2747_CR24","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1200\/JCO.2023.41.17_suppl.5004","volume":"41","author":"K Fizazi","year":"2023","unstructured":"Fizazi\u00a0K et\u00a0al (2023) J\u00a0Clin Oncol 41(suppl\u00a017):5004\u20135004. https:\/\/doi.org\/10.1200\/JCO.2023.41.17_suppl.5004","journal-title":"J Clin Oncol"},{"issue":"suppl\u00a05","key":"2747_CR25","first-page":"S1374","volume":"36","author":"SH Tolmeijer","year":"2025","unstructured":"Tolmeijer\u00a0SH et\u00a0al (2025) Ann Oncol 36(suppl\u00a05):S1374\u2013S1375 (Abstract 2457P)","journal-title":"Ann Oncol"},{"issue":"suppl\u00a017","key":"2747_CR26","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1200\/JCO.2022.40.17_suppl.5020","volume":"40","author":"S Sandhu","year":"2022","unstructured":"Sandhu\u00a0S et\u00a0al (2022) J\u00a0Clin Oncol 40(suppl\u00a017):5020\u20135020. https:\/\/doi.org\/10.1200\/JCO.2022.40.17_suppl.5020","journal-title":"J Clin Oncol"},{"key":"2747_CR27","unstructured":"Gemeinsamer Bundesausschuss. Dossier Olaparib (20.\u00a0Apr 2023)"},{"key":"2747_CR28","unstructured":"Gemeinsamer Bundesausschuss. Dossier Talazoparib (20.\u00a0Feb 2020)"},{"key":"2747_CR29","unstructured":"Gemeinsamer Bundesausschuss. Dossier Niraparib\/Abirateronacetat (09.\u00a0Feb 2024)"},{"key":"2747_CR30","unstructured":"S3-Leitlinie Prostatakarzinom. Version\u00a08.1 (August 2025) AWMF-Registernr.: 043\/022OL"},{"issue":"suppl\u00a017","key":"2747_CR31","first-page":"LBA5006","volume":"43","author":"G Attard","year":"2025","unstructured":"Attard\u00a0G et\u00a0al (2025) J\u00a0Clin Oncol 43(suppl\u00a017):LBA5006","journal-title":"J Clin Oncol"},{"key":"2747_CR32","unstructured":"ClinicalTrials.gov Identifier: NCT04821622. A\u00a0Study of Talazoparib With Enzalutamide in Men With DDR-Deficient Metastatic Castration-Sensitive Prostate Cancer (TALAPRO-3). Aufgerufen Oktober, 2025."},{"key":"2747_CR33","unstructured":"ClinicalTrials.gov Identifier: NCT06120491. Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician\u2019s Choice New Hormonal Agents (EvoPAR-PR01). Aufgerufen Oktober, 2025."}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02747-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-025-02747-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02747-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:57:47Z","timestamp":1777460267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-025-02747-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1007\/s00120-025-02747-7","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Ohlmann, C.\u00a0Gratzke und L.-M.\u00a0Krabbe haben im Zuge der Erstellung der Ver\u00f6ffentlichung ein Beraterhonorar erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}